ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has achieved an A-rating for its
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that the Company is today posting to
ECO Animal Health’s David Hallas discusses a strong set of results, growth drivers, product markets and optimism for the year ahead in this exclusive interview with DirectorsTalk.
ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the year ended 31st March 2023. David talks us through the highlights, explains what was behind
ECO Animal Health Group plc (LON:EAH) have today provided final results for the year ended 31 March 2023. HIGHLIGHTS Financial · Revenue and adjusted EBITDA ahead of market expectations · Group sales increased
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will issue its results for the year ended 31
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has provided an update to its expected results
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be participating at the
Eco Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk Interviews to discuss interim results for the six months ended 20th September. David talks us through the highlights, improved Chinese
ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2022. HIGHLIGHTS Financials · Group Sales at £34.9 million (H1 2021: £38.5 million) – China
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
